AgingResearch.NewsJoin free

Solid second primary malignant neoplasm

There is 1 paper on solid second primary malignant neoplasm in aging research: 1 observational study in people.

Disease

1 paper studies it2 findings

See all 1 papers on solid second primary malignant neoplasm

“The overall risk of a solid second primary malignant neoplasm was elevated (RR, 1.88; 95% CI, 1.59-2.21)”
Age-Specific Risk of Second Primary Malignant Neoplasm After Radioactive Iodine Treatment for Differentiated Thyroid CancerJAMA otolaryngology-- head & neck surgery2025doi:10.1001/jamaoto.2025.2626
  • Humans1

Interventions

1

Radioactive iodine

no changein humans1RR 0.94

1 study

  1. Radioactive iodine was not clearly linked with solid second primary malignant neoplasm in humans (nonmetastatic differentiated thyroid cancer) (RR 0.94, 95% CI 0.76-1.16).

    “The overall risk of a solid second primary malignant neoplasm was not elevated (RR, 0.94; 95% CI, 0.76-1.16)”

    Humansnonmetastatic differentiated thyroid cancer

    Age-Specific Risk of Second Primary Malignant Neoplasm After Radioactive Iodine Treatment for Differentiated Thyroid Cancer

    JAMA otolaryngology-- head & neck surgery

More on Radioactive iodine

Associations

1

Radioactive iodine

upin humans1RR 1.88

1 study

  1. Radioactive iodine is linked with a higher risk of solid second primary malignant neoplasm in humans (nonmetastatic differentiated thyroid cancer) (RR 1.88, 95% CI 1.59-2.21).

    “The overall risk of a solid second primary malignant neoplasm was elevated (RR, 1.88; 95% CI, 1.59-2.21)”

    Humansnonmetastatic differentiated thyroid cancer

    Age-Specific Risk of Second Primary Malignant Neoplasm After Radioactive Iodine Treatment for Differentiated Thyroid Cancer

    JAMA otolaryngology-- head & neck surgery

More on Radioactive iodine

Latest

Related